Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Font Size

Prostate Biopsies Help Tailor Treatment

Second Study Suggests Genetic Test Can Help Avoid Unneeded Biopsies
WebMD Health News
Reviewed by Louise Chang, MD

Feb. 15, 2008 (San Francisco) -- A biopsy reveals more important information about a man's prostate cancer than previously understood, a new study shows.

Other research suggests that a genetic test can help to spare thousands of men from the discomfort and misery of unnecessary biopsies.

Both studies were presented here at the 2008 Genitourinary Cancers Symposium, sponsored by the American Society of Clinical Oncology (ASCO) and two other cancer care organizations.

A Better Predictor of Persistent Prostate Cancer

Philadelphia researchers studied more than 300 men who were undergoing radiation treatment for prostate cancer. They found that the location and amount of cancer found on a biopsy prior to treatment were predictive of whether a man would have persistent disease after treatment -- and where the cancerous cells would be located.

Currently, doctors monitor PSA levels after radiation treatment to determine if prostate cancer has come back. But PSA gives an incomplete snapshot of a patient's outlook, says Mark K. Buyyounouski, MD, attending physician in radiation oncology at Fox Chase Cancer Center.

Seeking to find a better predictor of recurrence, the researchers compared prostate biopsies taken before treatment with those taken two years after treatment. All the men had cancers that were classified as intermediate or high risk.

"What we found is that men who had bigger tumors at first biopsy were more likely to have local persistence of the disease on the same side of the prostate after treatment," Buyyounouski says.

Left untreated, locally persistent prostate cancer may result in later spread of the disease and possibly death, he says.

ASCO spokesman Eric A. Klein, MD, head of urologic oncology at Cleveland Clinic, says the information is important because it gives doctors an opportunity to tailor treatment, such as by targeting higher-dose radiation the first time around to an area that contains a large tumor.

Buyyounouski tells WebMD that the researchers plan to test that strategy in an upcoming study.

Avoiding Unnecessary Prostate Biopsies

The second study involved men who did not have signs of prostate cancer on their first biopsy but were thought to be at high risk of developing the disease because of high PSA levels, atypical, irregular cell growth, or other factors.

Today on WebMD

man with doctor
Symptoms, risks, treatments
man coughing
Men shouldn’t ignore
prostate cancer cells
What does this diagnosis mean?
doctor and male patient
Is it worth it?
cancer fighting foods
15 Cancer Symptoms Men Ignore
Prostate Enlarged
Picture Of The Prostate
Prostate Cancer Quiz
screening tests for men
Prostate Cancer Symptoms
Vitamin D